BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 2186763)

  • 1. [Cerebral circulation and calcium antagonists].
    Uematsu D; Fukuuchi Y
    No To Shinkei; 1990 Jan; 42(1):17-31. PubMed ID: 2186763
    [No Abstract]   [Full Text] [Related]  

  • 2. [Agents to improve cerebrovascular circulation and cerebral metabolism--calcium antagonists].
    Kyoi K; Utsumi S
    Nihon Rinsho; 1985 Feb; 43(2):368-71. PubMed ID: 3889411
    [No Abstract]   [Full Text] [Related]  

  • 3. [Calcium antagonists and cerebrovascular circulation].
    De Gregorio C
    Clin Ter; 1987 Oct; 123(1):41-50. PubMed ID: 2972466
    [No Abstract]   [Full Text] [Related]  

  • 4. [Vascular and neuronal mechanisms of calcium antagonists. Significance in neurological therapy].
    Govoni S; Trabucchi M; Battaini F; Magnoni MS; Paoletti R
    Minerva Med; 1986 Jun; 77(24):1053-8. PubMed ID: 3725133
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Calcium inhibitors: effects on cerebral blood flow and intracranial pressure].
    Payen D; Lamer C; Raggueneau JL
    Agressologie; 1989 Jun; 30(7):408-10. PubMed ID: 2817237
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Cerebral protective effects by continuous administration of a calcium antagonist after canine global brain ischemia--change in cerebral blood flow and metabolism].
    Ono K; Iwatsuki N; Obara S; Hashimoto Y
    Masui; 1988 Jan; 37(1):23-8. PubMed ID: 3367498
    [No Abstract]   [Full Text] [Related]  

  • 7. Hemodynamic influences of azelnidipine, a novel calcium channel blocker, on cerebral circulation in hypertensive patients with ischemic white matter lesions.
    Kimura Y; Kitagawa K; Oku N; Kajimoto K; Kato H; Tanaka M; Sakaguchi M; Hougaku H; Sakoda S; Hatazawa J
    Hypertens Res; 2008 Dec; 31(12):2147-54. PubMed ID: 19139604
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Cerebrovascular circulation and metabolism. Action of calcium overload blockers].
    Fortschr Med Suppl; 1985; 8():10-1. PubMed ID: 2867017
    [No Abstract]   [Full Text] [Related]  

  • 9. [Brain protection must be simultaneously specific and complex. Versatile effect of certain calcium antagonists].
    Fortschr Med Suppl; 1985; 8():18-9. PubMed ID: 2867022
    [No Abstract]   [Full Text] [Related]  

  • 10. [Calcium channel blockers and cerebral circulation].
    Uematsu D; Fukuuchi Y
    Nihon Rinsho; 1989 Aug; 47(8):1770-5. PubMed ID: 2585739
    [No Abstract]   [Full Text] [Related]  

  • 11. [Calcium antagonists in the therapy of cerebrovascular diseases].
    Cosmi F
    Clin Ter; 1985 Mar; 112(5):465-8. PubMed ID: 4017471
    [No Abstract]   [Full Text] [Related]  

  • 12. [Calcium, calcium antagonists and cerebral circulation].
    Beketov AI; Gromova TM
    Farmakol Toksikol; 1988; 51(2):103-7. PubMed ID: 2454201
    [No Abstract]   [Full Text] [Related]  

  • 13. [Calcium antagonists and cerebral circulation].
    Bes A; Géraud G; Fabre N
    Rev Prat; 1988 Nov; 38(27):1983-5. PubMed ID: 3206150
    [No Abstract]   [Full Text] [Related]  

  • 14. [Comparative study of dilceren (nimodipine) on the cerebral circulation in the intact animals and animals subjected to ischemic brain damage].
    Aleksandrin VV; Khaĭlov NA; Mirzoian GR; Gan'shina TS
    Eksp Klin Farmakol; 2002; 65(2):17-9. PubMed ID: 12109284
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of calcium channel blockers in acute ischemic cerebrovascular disease.
    Sood AK; Dua A; Mahajan A; Arora S
    J Assoc Physicians India; 1996 Jan; 44(1):70. PubMed ID: 8773106
    [No Abstract]   [Full Text] [Related]  

  • 16. Pathophysiology of the cerebral circulation.
    Ravussin P; Bracco D
    Acta Anaesthesiol Scand Suppl; 1997; 111():89-91. PubMed ID: 9420967
    [No Abstract]   [Full Text] [Related]  

  • 17. (S)-emopamil, a novel calcium and serotonin antagonist for the treatment of cerebrovascular disorders. 3rd communication: effect on postischemic cerebral blood flow and metabolism, and ischemic neuronal cell death.
    Szabo L; Hofmann HP
    Arzneimittelforschung; 1989 Mar; 39(3):314-9. PubMed ID: 2757657
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Therapy in the early stage of cerebral insufficiency. Clinical and technical possibilities for evaluating the vascular system].
    Fortschr Med Suppl; 1986; 1():9-10. PubMed ID: 2868982
    [No Abstract]   [Full Text] [Related]  

  • 19. Prevention, treatment, and resuscitation of cerebral ischemia.
    Illievich UM; Dumitrescu RV; Papousek A; Schreier H; Glaser C; Klimscha W
    Acta Anaesthesiol Scand Suppl; 1997; 111():95-9. PubMed ID: 9420970
    [No Abstract]   [Full Text] [Related]  

  • 20. [The effect of vasoactive preparations on the systemic and cerebral hemodynamics and on the blood rheological properties in patients with cerebrovascular insufficiency with a background of an atherosclerotic lesion of the precerebral arteries].
    Ishchenko MM; Shkrobot SI; Ostrovs'ka OS
    Lik Sprava; 1994; (7-8):133-6. PubMed ID: 7900337
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.